About the Project |  FAQs |  Glossary |  Data Sources |  Bibliography |  Complete Indicator List
CKD Surveillance Search Results



X
Try double quotes " " around multiple terms to search for an exact phrase.
  • (e.g.,"Acute Kidney Injury")

Use OR to search for pages with any of the provided terms.
  • (e.g.,"AKI" or "Acute Kidney Injury")



Indicators From Search Results
Most Recent Year
Data Source
Prevalence refers to the presence of a health-related condition (e.g., CKD) in a particular population at a specific point in time (point prevalence) or, less frequently, during a specific period (period prevalence); it may be expressed as a count (number of prevalent cases) or as the proportion of cases in the population (prevalence of the condition).

Percentage of Patients with ICD-9-CM or ICD-10-CM Codes Indicating CKD or ESRD
2020
CMS-Medicare, Clinformatics Commercial, Clinformatics Medicare Advantage, CMS-Medicaid
Percentage of Patients with an ICD-9-CM or ICD-10-CM Code Indicating CKD
2020
CMS-Medicare, NATIONAL VA, Clinformatics Commercial, Clinformatics Medicare Advantage, CMS-Medicaid, DoD-MHS
Identification of those at risk for development of CKD forms an integral part of a CKD surveillance system. First, examining changes in the burden of risk factors for CKD can help predict the potential future burden of CKD. For example, if the prevalence of an important risk factor is rising, it is likely that the prevalence of CKD will rise accordingly. Second, assessing the burden of risk factors can also help identify which interventions are likely to have the most impact on reducing the burden of CKD. Early intervention in those with risk factors may help prevent or delay the onset of CKD, or in the case of established CKD, help slow progression or reduce related morbidity and mortality.

Percentage of Patients with a Diagnosis of Diabetes
2020
CMS-Medicare, NATIONAL VA, Clinformatics Commercial, Clinformatics Medicare Advantage, CMS-Medicaid
Percentage of Patients with a Diagnosis of Hypertension
2020
CMS-Medicare, NATIONAL VA, Clinformatics Commercial, Clinformatics Medicare Advantage, CMS-Medicaid
Age of Patients
2020
CMS-Medicare, NATIONAL VA, Clinformatics Commercial, Clinformatics Medicare Advantage, CMS-Medicaid, DoD-MHS
Percentage of Patients by Race/Ethnicity
2020
CMS-Medicare, NATIONAL VA, Clinformatics Commercial, Clinformatics Medicare Advantage, CMS-Medicaid, DoD-MHS




Suggested Citation:
Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System—United States.
website. http://www.cdc.gov/ckd